Tongling Jieya Biologic Technology Co., Ltd. (SHE:301108)
China · Delayed Price · Currency is CNY 35.60
+1.71 (5.05%)
At close: Jul 31, 2026
SHE:301108 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 840.58 | 772.01 | 547.45 | 622.59 | 666.56 | 984.45 |
Revenue Growth | 55.24% | 41.02% | -12.07% | -6.60% | -32.29% | 32.50% |
Gross Profit Gross Profit Growth | 210.75 | 187.13 | 99.24 | 180.32 | 204.59 | 316.58 |
Operating Income Operating Income Growth | 94.81 | 82.79 | 18.63 | 102.63 | 134.75 | 243.31 |
Net Income Net Income Growth | 77.48 | 77.27 | 19.46 | 115.2 | 140.97 | 220.05 |
Earnings Per Share EPS Growth | 0.63 | 0.68 | 0.17 | 1.01 | 1.24 | 2.51 |
EPS Growth | 324.83% | 300.00% | -83.24% | -18.39% | -50.57% | 19.32% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
China China Growth | 252.45 | 286.37 | 335.58 | 276.41 | 256.17 |
Foreign Foreign Growth | 519.56 | 261.08 | 287.01 | 390.15 | 728.27 |
Total Total Growth | 772.01 | 547.45 | 622.59 | 666.56 | 984.45 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 967.73 | 1,138 | 1,492 | 1,340 | 1,305 | 1,416 |
Total Debt Total Debt Growth | 98.29 | 37.64 | 8.67 | 17.91 | 31.89 | 39.96 |
Net Cash (Debt) Net Cash Growth | 869.43 | 1,100 | 1,484 | 1,322 | 1,273 | 1,376 |
Net Cash Growth | -38.83% | -25.82% | 12.24% | 3.81% | -7.44% | 407.47% |
Net Cash Per Share Net Cash Per Share Growth | 7.08 | 9.68 | 12.96 | 11.64 | 11.23 | 15.72 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 124.25 | 99.17 | 75.12 | 83.51 | 299.02 | 200.18 |
Capital Expenditures CapEx Growth | -327.57 | -367.95 | -96.23 | -85.05 | -29.91 | -72.59 |
Free Cash Flow Free Cash Flow Growth | -203.31 | -268.78 | -21.11 | -1.54 | 269.1 | 127.59 |
Free Cash Flow Growth | - | - | - | - | 110.91% | 51.25% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 25.07% | 24.24% | 18.13% | 28.96% | 30.69% | 32.16% |
Operating Margin | 11.28% | 10.72% | 3.40% | 16.48% | 20.21% | 24.71% |
Pretax Margin | 10.34% | 11.22% | 4.59% | 21.68% | 24.33% | 25.58% |
Profit Margin | 9.22% | 10.01% | 3.56% | 18.50% | 21.15% | 22.35% |
FCF Margin | -24.19% | -34.82% | -3.86% | -0.25% | 40.37% | 12.96% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.300 | 0.250 | 0.100 | 0.257 | 0.357 | 0.536 |
Dividend Per Share Growth | 150.00% | 150.00% | -61.10% | -28.00% | -33.34% | - |
Dividend Yield | 0.84% | 0.76% | 0.55% | 1.07% | 1.54% | 1.32% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 56.43 | 48.45 | 106.36 | 24.35 | 19.45 | 22.21 |
Forward PE | 16.56 | 16.26 | 14.31 | 19.19 | 15.76 | - |
P/FCF Ratio | - | - | - | - | 10.19 | 38.30 |
PS Ratio | 4.77 | 4.85 | 3.78 | 4.51 | 4.11 | 4.96 |